Annual Total Liabilities:
$138.94M+$11.14M(+8.72%)Summary
- As of today, RNA annual total liabilities is $138.94 million, with the most recent change of +$11.14 million (+8.72%) on December 31, 2024.
- During the last 3 years, RNA annual total liabilities has risen by +$92.79 million (+201.05%).
- RNA annual total liabilities is now -14.38% below its all-time high of $162.26 million, reached on December 31, 2019.
Performance
RNA Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Total Liabilities:
$247.94M+$71.68M(+40.67%)Summary
- As of today, RNA quarterly total liabilities is $247.94 million, with the most recent change of +$71.68 million (+40.67%) on September 30, 2025.
- Over the past year, RNA quarterly total liabilities has increased by +$110.55 million (+80.47%).
- RNA quarterly total liabilities is now at all-time high.
Performance
RNA Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
RNA Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +8.7% | +80.5% |
| 3Y3 Years | +201.1% | +362.9% |
| 5Y5 Years | -14.4% | +854.8% |
RNA Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +201.1% | at high | +380.5% |
| 5Y | 5-Year | -14.4% | +402.0% | at high | +854.8% |
| All-Time | All-Time | -14.4% | +402.0% | at high | +889.4% |
RNA Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2025 | - | $247.94M(+40.7%) |
| Jun 2025 | - | $176.26M(+35.2%) |
| Mar 2025 | - | $130.35M(-6.2%) |
| Dec 2024 | $138.94M(+8.7%) | $138.94M(+1.1%) |
| Sep 2024 | - | $137.39M(+8.7%) |
| Jun 2024 | - | $126.39M(+4.8%) |
| Mar 2024 | - | $120.58M(-5.6%) |
| Dec 2023 | $127.79M(+110.4%) | $127.79M(+129.4%) |
| Sep 2023 | - | $55.70M(+7.9%) |
| Jun 2023 | - | $51.61M(-6.3%) |
| Mar 2023 | - | $55.06M(-9.3%) |
| Dec 2022 | $60.73M | $60.73M(+13.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | $53.56M(+15.3%) |
| Jun 2022 | - | $46.45M(+2.3%) |
| Mar 2022 | - | $45.43M(-1.6%) |
| Dec 2021 | $46.15M(+66.8%) | $46.15M(+48.7%) |
| Sep 2021 | - | $31.04M(+19.2%) |
| Jun 2021 | - | $26.04M(-9.1%) |
| Mar 2021 | - | $28.64M(+3.5%) |
| Dec 2020 | $27.68M(-82.9%) | $27.68M(+6.6%) |
| Sep 2020 | - | $25.97M(+3.6%) |
| Jun 2020 | - | $25.06M(-84.7%) |
| Mar 2020 | - | $163.64M(+0.8%) |
| Dec 2019 | $162.26M(+259.7%) | $162.26M |
| Dec 2018 | $45.11M | - |
FAQ
- What is Avidity Biosciences, Inc. annual total liabilities?
- What is the all-time high annual total liabilities for Avidity Biosciences, Inc.?
- What is Avidity Biosciences, Inc. annual total liabilities year-on-year change?
- What is Avidity Biosciences, Inc. quarterly total liabilities?
- What is the all-time high quarterly total liabilities for Avidity Biosciences, Inc.?
- What is Avidity Biosciences, Inc. quarterly total liabilities year-on-year change?
What is Avidity Biosciences, Inc. annual total liabilities?
The current annual total liabilities of RNA is $138.94M
What is the all-time high annual total liabilities for Avidity Biosciences, Inc.?
Avidity Biosciences, Inc. all-time high annual total liabilities is $162.26M
What is Avidity Biosciences, Inc. annual total liabilities year-on-year change?
Over the past year, RNA annual total liabilities has changed by +$11.14M (+8.72%)
What is Avidity Biosciences, Inc. quarterly total liabilities?
The current quarterly total liabilities of RNA is $247.94M
What is the all-time high quarterly total liabilities for Avidity Biosciences, Inc.?
Avidity Biosciences, Inc. all-time high quarterly total liabilities is $247.94M
What is Avidity Biosciences, Inc. quarterly total liabilities year-on-year change?
Over the past year, RNA quarterly total liabilities has changed by +$110.55M (+80.47%)